MetaCap

Veraxa Biotech AG (VRXA)

NASDAQ: VRXAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.04+0.01 (+0.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

VRXA stock chart

Technical analysis

Key statistics

All statistics
Market cap
$147.06M
EPS (TTM)
-$0.57
52-week range
0.90 – 27.36
Day range
1.03 – 1.06
Volume / Avg
114.63K / 267.82K
Beta
—

52-week range

$0.90$27.36

VRXA stock today

On Nov 20, VRXA ended the session at $1.04, adding $0.01 (0.97%), versus the S&P 500's 3.70% decline. Trading was light, with 114.63K shares changing hands, about 43% of the average daily volume. Shares are 96.2% below their 52-week high of $27.36, set on Jun 11, 2026 and 15.6% above the 52-week low of $0.90, near the bottom of the past year's range.

VRXA is down 90.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 90.1%. Veraxa Biotech has posted a net loss over the last twelve months (EPS of -$0.57), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Veraxa Biotech

Company profile

Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Christoph Antz Ph.D.
Headquarters
Zurich
Website
veraxa.com

VRXA news

All VRXA news

Veraxa Biotech peers

Health Care sector
VRXA peer companies
CompanyPrice% ChgMarket capCompare
BBOTBridgeBio Oncology Therapeutics Inc.1.81-2.69%$145.25Mvs VRXA
PRQRProQR Therapeutics N.V.1.04-0.95%$146.98Mvs VRXA
RNAAtrium Therapeutics Inc.6.92-0.86%$149.27Mvs VRXA
ELDNEledon Pharmaceuticals Inc.1.78-6.32%$150.34Mvs VRXA
IFRXInflaRx N.V.1.04-4.59%$153.26Mvs VRXA
ALXOALX Oncology Holdings Inc.1.06+3.92%$137.03Mvs VRXA
ORMPOramed Pharmaceuticals Inc.3.57-3.25%$155.24Mvs VRXA
ZNTLZentalis Pharmaceuticals Inc.1.360.00%$133.64Mvs VRXA

Indexes, lists and sector

Veraxa Biotech stock FAQ

What is Veraxa Biotech's stock price today?

VRXA last traded at $1.04 as of Nov 20, 4:00 PM EST, up 0.97% on the day. Prices are delayed at least 15 minutes.

Who is Veraxa Biotech's CEO?

Dr. Christoph Antz Ph.D. is the chief executive officer of Veraxa Biotech AG.

What is the VRXA 52-week high?

The 52-week high for VRXA is $27.36 and the 52-week low is $0.90. The stock is currently 96.2% below its high.

Compare VRXA